CS167902B2 - - Google Patents
Info
- Publication number
- CS167902B2 CS167902B2 CS81470A CS81470A CS167902B2 CS 167902 B2 CS167902 B2 CS 167902B2 CS 81470 A CS81470 A CS 81470A CS 81470 A CS81470 A CS 81470A CS 167902 B2 CS167902 B2 CS 167902B2
- Authority
- CS
- Czechoslovakia
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB3125569 | 1969-06-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS167902B2 true CS167902B2 (enEXAMPLES) | 1976-05-28 |
Family
ID=10320364
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS81470A CS167902B2 (enEXAMPLES) | 1969-06-20 | 1970-06-19 |
Country Status (5)
| Country | Link |
|---|---|
| AT (1) | AT300820B (enEXAMPLES) |
| BR (1) | BR6915221D0 (enEXAMPLES) |
| CS (1) | CS167902B2 (enEXAMPLES) |
| GB (1) | GB1260886A (enEXAMPLES) |
| PL (1) | PL92088B1 (enEXAMPLES) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2575158B1 (fr) * | 1984-12-20 | 1987-10-02 | Pf Medicament | Arylalcoyloxymethyl-2 morpholines, leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central |
| AU3364493A (en) * | 1992-01-28 | 1993-09-01 | Smithkline Beecham Plc | Compounds as calcium channel antagonists |
| ATE287878T1 (de) | 1996-08-23 | 2005-02-15 | Neurosearch As | Disubstituierte morpholin-, oxazepin- oder thiazepinderivate, deren herstellung und verwendung als dopamin-d4-rezeptorantagonisten |
| US7294637B2 (en) | 2000-09-11 | 2007-11-13 | Sepracor, Inc. | Method of treating addiction or dependence using a ligand for a monamine receptor or transporter |
| EP1318988A2 (en) | 2000-09-11 | 2003-06-18 | Sepracor, Inc. | Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission) |
| GEP20084550B (en) | 2004-04-30 | 2008-11-25 | Warner Lambert Co | Substituted morpholine compounds for the treatment of central nervous system disorders |
| BRPI0717596B8 (pt) | 2006-10-18 | 2021-05-25 | Pfizer Prod Inc | compostos de éter biarílico uréia, seu uso e composição farmacêutica que os compreende |
| KR20230175199A (ko) | 2021-03-18 | 2023-12-29 | 슈퍼너스 파마슈티컬스, 인크. | 치환된 몰폴린의 유도체 및 이의 용도 |
| WO2024206307A2 (en) | 2023-03-27 | 2024-10-03 | Supernus Pharmaceuticals, Inc. | Derivatives of substituted morpholines and uses thereof |
-
1969
- 1969-06-20 GB GB5013069A patent/GB1260886A/en not_active Expired
- 1969-12-16 BR BR21522169A patent/BR6915221D0/pt unknown
-
1970
- 1970-06-06 PL PL18255570A patent/PL92088B1/pl unknown
- 1970-06-19 CS CS81470A patent/CS167902B2/cs unknown
- 1970-06-22 AT AT562170A patent/AT300820B/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PL92088B1 (enEXAMPLES) | 1977-03-31 |
| AT300820B (de) | 1972-08-10 |
| BR6915221D0 (pt) | 1973-02-13 |
| GB1260886A (en) | 1972-01-19 |